Trial Outcomes & Findings for Feasibility of Depression Care Management by E-mail (NCT NCT00755235)
NCT ID: NCT00755235
Last Updated: 2017-11-13
Results Overview
20-item depression severity scalse adapted from longer SCL-90. Mean score ranges from 0 to 4 with scores above 1.5 indicating moderate depression.
COMPLETED
NA
208 participants
Measured at baseline and after 6 months of treatment
2017-11-13
Participant Flow
Participant milestones
| Measure |
Secure Messaging Care Management
Participants will receive depression care management by secure messaging.
|
Usual Care
Participants will receive their usual care, with no additional education or care management services.
|
|---|---|---|
|
Overall Study
STARTED
|
106
|
102
|
|
Overall Study
COMPLETED
|
104
|
93
|
|
Overall Study
NOT COMPLETED
|
2
|
9
|
Reasons for withdrawal
Withdrawal data not reported
Baseline Characteristics
Feasibility of Depression Care Management by E-mail
Baseline characteristics by cohort
| Measure |
Secure Messaging Care Management
n=106 Participants
Participants will receive depression care management by secure messaging.
|
Usual Care
n=102 Participants
Participants will receive their usual care, with no additional education or care management services.
|
Total
n=208 Participants
Total of all reporting groups
|
|---|---|---|---|
|
Age, Categorical
<=18 years
|
0 Participants
n=5 Participants
|
0 Participants
n=7 Participants
|
0 Participants
n=5 Participants
|
|
Age, Categorical
Between 18 and 65 years
|
96 Participants
n=5 Participants
|
94 Participants
n=7 Participants
|
190 Participants
n=5 Participants
|
|
Age, Categorical
>=65 years
|
10 Participants
n=5 Participants
|
8 Participants
n=7 Participants
|
18 Participants
n=5 Participants
|
|
Age, Continuous
|
48 years
STANDARD_DEVIATION 9 • n=5 Participants
|
48 years
STANDARD_DEVIATION 10 • n=7 Participants
|
48 years
STANDARD_DEVIATION 9 • n=5 Participants
|
|
Sex: Female, Male
Female
|
76 Participants
n=5 Participants
|
74 Participants
n=7 Participants
|
150 Participants
n=5 Participants
|
|
Sex: Female, Male
Male
|
30 Participants
n=5 Participants
|
28 Participants
n=7 Participants
|
58 Participants
n=5 Participants
|
|
Region of Enrollment
United States
|
106 participants
n=5 Participants
|
102 participants
n=7 Participants
|
208 participants
n=5 Participants
|
PRIMARY outcome
Timeframe: Measured at baseline and after 6 months of treatmentPopulation: Analysis included all participants participating in outcome assessment
20-item depression severity scalse adapted from longer SCL-90. Mean score ranges from 0 to 4 with scores above 1.5 indicating moderate depression.
Outcome measures
| Measure |
Secure Messaging Care Management
n=104 Participants
Participants will receive depression care management by secure messaging.
|
Usual Care
n=93 Participants
Participants will receive their usual care, with no additional education or care management services.
|
|---|---|---|
|
20-Item Symptom Checklist Depression Scale
|
0.95 units on a scale
Standard Deviation 0.71
|
1.17 units on a scale
Standard Deviation 0.81
|
SECONDARY outcome
Timeframe: Measured after 6 months of treatmentSingle item seven point scale ranging from "very satisfied" to "very dissatisfied"
Outcome measures
| Measure |
Secure Messaging Care Management
n=104 Participants
Participants will receive depression care management by secure messaging.
|
Usual Care
n=93 Participants
Participants will receive their usual care, with no additional education or care management services.
|
|---|---|---|
|
Treatment Satisfaction
Very Satisfied
|
56 participants
|
31 participants
|
|
Treatment Satisfaction
Less than very satisfied
|
48 participants
|
62 participants
|
Adverse Events
Secure Messaging Care Management
Usual Care
Serious adverse events
| Measure |
Secure Messaging Care Management
n=104 participants at risk
Participants will receive depression care management by secure messaging.
|
Usual Care
n=93 participants at risk
Participants will receive their usual care, with no additional education or care management services.
|
|---|---|---|
|
Psychiatric disorders
Suicide attempt
|
0.00%
0/104
|
0.00%
0/93
|
Other adverse events
Adverse event data not reported
Additional Information
Gregory Simon, Principal Investigator
Group Health Research Institute
Results disclosure agreements
- Principal investigator is a sponsor employee
- Publication restrictions are in place